Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: VelaSmooth Users: Cosmetic Dermatologists(?)

Council Members in this Study Group: 14

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

What is a GLG Leader?
Brian Lester, MD
Dermatologist
Brian W Lester, MD

Brian Lester, MD, is a Dermatologist in private practice in Massachusetts. His interests include clinical dermatology, cosmetic dermatology, dermatopathology, and dermatologic pharmaceuticals. He has experience with clinical trials involving a variety of agents used in psoriasis (e.g. retinoids and...


Michele Pauporte, MD, Dermatologist, Juva Skin and Laser CenterMichele Pauporte, MD
Dermatologist
Juva Skin and Laser Center

Michele Pauporte, MD, is a Dermatologist at Juva Skin and Laser Center, in New York City. Dr. Pauporte's areas of expertise include cosmetic procedures and the treatment of skin cancers (including Mohs micrographic surgery) and reconstructive surgery. She is also extremely experienced in the use of...


Kenneth Edelson
Owner
Kenneth Edelson, MD

Kenneth Edelson, MD, FAACS, is a Dermatologist in private practice in New York. Dr. Edelson specializes in skin cancer as well as cosmetic dermatology, including lasers and IPL's for facial rejuvenation and skin tightening, vascular lesions, pigmentation, and cellulite. He also uses lasers for leg veins...


6 recent news post(s)

Related Study Groups

GLG NewsSMAnalyses by this Study Group's Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Cost is key, but not enough! | 12-17-2007
Analysis of: Ipsen and Medicis announce submission of Reloxin(R) in aesthetics to the FDA | www.pipelinereview.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD

Lowering cost of Botox is key, but not enough to induce patients to undergo Botox treatments.

Reloxin Gives Allergan's Botox A Run for the Money! | 12-13-2007
Analysis of: Ipsen and Medicis announce submission of Reloxin(R) in aesthetics to the FDA | www.pipelinereview.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD

For too long Allergan has monopolized the therapeutic and cosmetic market of botulinum toxin type A, and has taken full advantage of that monopoly by raising the price of Botox almost biannually. Reloxin studies are very favorable when compared to Botox, and may even surpass it in one or two aspects....

New Organiceuticals May Help Bring Back Beauty! | 05-29-2007
Analysis of: http://www.nytimes.com/2007/04/26/fashion/26skin.html?_r=1&ref=health&oref=slogin | www.nytimes.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD

All that glitters is not gold...but some might be! Anti-oxidants are the promise of saving our "hides"!

Couldn't agree more | 05-28-2007
Analysis of: FDA May Place Ban on OTC Bleaching Creams | www.carefair.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD

Keep Hydroquinones Around!

Non-Invasive Screening of the Skin | 05-17-2007
Analysis of: New tool allows noninvasive screening of skin lesions | www.modernmedicine.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD

The company hopes to apply for European regulatory approval next year, with U.S. market approval and launch to follow. The current price of the device is 15,000 EUR. This device promises to be a remarkable time and money saver for medicine. Approximately 80-95% of lesions excised by dermatologists prove...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Office Based Private Practice or Clinic
  • Academic Institution*
  • Free-standing Surgery Center

Most Common Job Types:

  • Owner
  • Physician - Attending Physician
  • Allied Health Professional
  • Director
  • Operations Executive
  • Professor
  • Principal

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics